Multiple etiologies of tumor hypoxia require multifaceted solutions

Clinical Cancer Research

Volumn 13, Issue 2 I, 2007, Pages 375-377

  Dewhirst, Mark W ^a,b,d   Navia, Isabel Cardenas ^b   Brizel, David M ^a   Willett, Christopher ^a   Secomb, Timothy W ^c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Duke University   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOGEN; DEXAMETHASONE; ERYTHROPOIETIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 8; NICOTINAMIDE; STEROID; VASCULOTROPIN;

BLADDER CANCER; CANCER INVASION; CANCER RESEARCH; CLINICAL TRIAL; COMPUTER SIMULATION; HUMAN; HYPOXIA; NOTE; OXYGEN CONCENTRATION; PRIORITY JOURNAL; TUMOR GROWTH;

ANOXIA; CELL HYPOXIA; GLUCOCORTICOIDS; HUMANS; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; NEOPLASMS; OXYGEN; OXYGEN CONSUMPTION; PERFUSION; STEROIDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846875466     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-2629     Document Type: Note

References (35)

1. Crokart N, Jordan BF, Baudelet C, et al. Glucocorticoids modulate tumor radiation response through a decrease in tumor oxygen consumption. Clin Cancer Res 2007;13:630-5.
2. Vaupel P, Harrison L. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 2004;9 Suppl 5:4-9.
3. Overgaard J, Horsman MR. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol 1996;6:10-21.
4. Suh JH, Stea B, Nabid A, et al. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. J Clin Oncol 2006;24:106-14.
5. Henke M, Laszig R, Rube C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003;362:1255-60.
6. Kaanders JH, Bussink J, van der Kogel AJ. Clinical studies of hypoxia modification in radiotherapy. Semin Radiat Oncol 2004;14:233-40.
7. Alonzi R, Hoskin P. Novel therapies in bladder cancer. Clin Oncol (R Coll Radiol) 2005;17:524-38.
8. Varlotto J, Stevenson MA. Anemia, tumor hypoxemia, and the cancer patient. Int J Radiat Oncol Biol Phys 2005;63:25-36.
9. Secomb TW, Hsu R, Park EY, Dewhirst MW. Green's function methods for analysis of oxygen delivery to tissue by microvascular networks. Ann Biomed Eng 2004;32:1519-29.
10. Secomb TW, Hsu R, Braun RD, Ross JR, Gross JF, Dewhirst MW. Theoretical simulation of oxygen transport to tumors by three-dimensional networks of microvessels. Adv Exp Med Biol 1998;454:629-34.
11. Dewhirst MW, Ong ET, Rosner GL, et al. Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content. Br J Cancer Suppl 1996;27:3241-6.
12. Sonveaux P, Dessy C, Martinive P, et al. Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment. Cancer Res 2004;64:3209-14.
13. Dewhirst MW, Ong ET, Klitzman B, et al. Perivascular oxygen tensions in a transplantable mammary tumor growing in a dorsal flap window chamber. Radiat Res 1992;130:171-82.
14. Kavanagh BD, Coffey BE, Needham D, Hochmuth RM, Dewhirst MW. The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, lactate treatment. Br J Cancer 1993;67:734-41.
15. Dewhirst MW, Ong ET, Madwed D, et al. Effects of the calcium channel blocker flunarizine on the hemodynamics and oxygenation of tumor microvasculature. Radiat Res 1992;132:61-8.
16. Kuo L, Pittman RN. Effect of hemodilution on oxygen transport in arteriolar networks of hamster striated muscle. Am J Physiol 1988;254:H331-9.
17. Duling BR, Berne RM. Longitudinal gradients in periarteriolar oxygen tension. A possible mechanism for the participation of oxygen in local regulation of blood flow. Circ Res 1970;27:669-78.
18. Brizel DM, Lin S, Johnson JL, Brooks J, Dewhirst MW, Piantadosi CA. The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation. Br J Cancer 1995;72:1120-4.
19. Brizel DM, Hage WD, Dodge RK, Munley MT, Piantadosi CA, Dewhirst MW. Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide. Radiat Res 1997;147: 715-20.
20. Shan SQ, Rosner GL, Braun RD, Hahn J, Pearce C, Dewhirst MW. Effects of diethylamine/nitric oxide on blood perfusion and oxygenation in the R3230Ac mammary carcinoma. Br J Cancer 1997;76:429-37.
21. Chan RC, Babbs CF, Vetter RJ, Lamar CH. Abnormal response of tumor vasculature to vasoactive drugs. J Natl Cancer Inst 1984;72:145-50.
22. Stone HB, Minchinton Al, Lemmon M, Menke D, Brown JM. Pharmacological modification of tumor blood flow: lack of correlation between alteration of mean arterial blood pressure and changes in tumor perfusion. Int J Radiat Oncol Biol Phys 1992;22: 79-86.
23. Sevick EM, Jain RK. Viscous resistance to blood flow in solid tumors: effect of hematocrit on intratumor blood viscosity. Cancer Res 1989;49:3513-9.
24. Sevick EM, Jain RK. Geometric resistance to blood flow in solid tumors perfused ex vivo : effects of tumor size and perfusion pressure. Cancer Res 1989;49:3506-12.
25. Wood PJ, Hirst DG. Modification of tumour response by calcium antagonists in the SCVII/St tumour implanted at two different sites. Int J Radiat Biol 1989;56:355-67.
26. Hori Y, Hu DE, Yasui K, Smither RL, Gresham GA, Fan TP. Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants. Br J Pharmacol 1996;118:1584-91.
27. Snyder SA, Lanzen JL, Braun RD, et al. Simultaneous administration of glucose and hyperoxic gas achieves greater improvement in tumor oxygenation than hyperoxic gas alone. Int J Radiat Oncol Biol Phys 2001;51:494-506.
28. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005;307:58-62.
29. Yano A, Fujii Y, Iwai A, Kageyama Y, Kihara K. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells. Clin Cancer Res 2006;12:3003-9.
30. Valledor AF, Ricote M. Nuclear receptor signaling in macrophages. Biochem Pharmacol 2004;67:201-12.
31. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006;66:605-12.
32. Ettinger D, Lin T. Antiemetic therapy. In: Kufe DR, Bast W, Hait W, et al. editors. Cancer Medicine. 7th ed. Hamilton: BC Decker, Inc; 2006. p. 2055-60.
33. Heimdahl K, Hirschberg H, Slettebo H, Watne K, Nome O. High incidence of serious side effects of high-dose dexamethazone treatment in patients with epidural spinal cord compression. Neuro-oncol 1992;12:141-4.
34. Ce P, Gedizlioglu M, Gelal F, Coban P, Ozbek G. Avascular necrosis of the bones: an overlooked complication of pulse steroid treatment of multiple sclerosis. Eur J Neurol 2006;13:857-61.
35. Gunal I, Karatosun V. Avascular necrosis of the femoral heads after single corticosteroid injection. CMAJ 2006;175:31.